Monday, November 17th

8h30-9h00 : Welcome Ceremony FN Gilly (Lyon, France)

9h00-9h30 : Opening Lecture PH Sugarbaker (Washington, USA)

                                    Moving from consensus to clinical integration with the help of intracavitary pharmacology 

9h30-11h00: Indications and place of imaging. Role of radiologists.

                        Chairmen: F Cotton (Lyon, France), DL Bartlett (Pittsburg, USA)

9h30-9h50: Cytoreductive surgery and intraperitonel chemotherapy: which peritoneal surface malignancy should be treated ? Recommendations.

                        P. Piso (Regensburg, Germany)

9h50-10h10: What should be expected from imaging before cytoreduction for peritoneal carcinomatosis: the surgeon's point of view.

                        S. Gonzales Moreno (Madrid, Spain)

10h10-10h30: Imaging and peritoneal carcinomatosis: what should be preoperative exams? The radiologist's point of view.

                        O. Pellet (Lyon, France)

10h30-11h00: Discussion

11h00-11h30: Coffee Break and Sponsor / Poster Visiting

11h30-13h00: How to improve patient selection. Role of general surgeons.

       Chairmen: V. Verwaal (Amsterdam, Netherland), H. Mahteme (Uppsala, Sweden)

11h30-11h50: Place of laparoscopy for the evaluation of carcinomatosis extent

                      M. Valle (Roma, Italy)

11h50-12h10: Recommendations to general surgeons for preoperative peritoneal carcinomatosis discovery

                       B. Moran (Basingtoke, UK)

12h10-12h30: Selection of patients with colorectal carcinomatosis for a procedure combining perioperative intraperitoneal chemotherapy. Proposition of guidelines.

                       M. Pocard (Paris, France)

12h30-13h00: Discussion.

13h00-14h30: Lunch and Sponsor / Poster Visiting

                                 Restaurant GAMBONI


14h30-15h45: Cytoreductive surgery. Technical aspects                        (Video-Photo)

         Chairmen: DM Kecmanovic (Belgrade, Serbia), P. Sugarbaker (Washington, USA)

14h30-14h45: Pelvic disease. Douglassectomy, Pelviperitonectomy.

                    D. Elias (Villejuif, France)

14h45-15h00: Bowel and mesentery disease. Anastomoses, Stomy.

                    S. O'Dwyer (Manchester, UK)

15h00-15h15: Parietal disease. Parietal peritonectomy (gutters, cupula), Scar removing

                    D. Bartlett (Pittsburg, USA)

15h15-15h30: Sus-mesocolic disease. Omental bursa, Lesser omentum, Cholecyctectomy and Gastrectomy.

                     V. Verwaal (Amsterdam, Netherlands)

15h30-15h45: Discussion.


16h00-18h20: Peritoneal Surface Malignancy. A multidisciplinary approach. Role of Anesthesiologists, Nutritionists, Nurses, Perfusionists.

                        Chairmen: KH Link (Wiesbaden, Belgium), AC Beaujard (Lyon, France)

16h00-16h20: A Belgian experience of starting carcinomatosis program

                    A. Kartheuser (Bruxelles, Belgium)

16h20-16h40: Treatment of postoperative surgical complications

                    A. Gomez Portilla (Vitoria, Spain)

16h40-17h00: Nutrition and quality of life following cytoreductive procedures

                    RP McQuellon (Winston Salem, USA)

17h00-17h20: Hyperthermic intraperitoneal chemotherapy: does the anesthesiological                    strategy differ from other extensive abdominal strategies ?

                    V. Billard (Villejuif, France)

17h20-17h40: Intraoperative parameters that could be markers of morbidity

                    S. Kusamura (Milan, Italy)

17h40-18h00: Nurses implications in perioperative management of patients treated by                     cytoreductive surgery and intraperitoneal chemotherapy

                    S. Alves (Basingstoke, UK)

18h00-18h20: Discussion.

18h30-19h00: "Rendez-vous" in front of ENS for bus.


Tuesday, November 18th

8h30-10h00: Colorectal Cancers

                   Chairmen: F. Antos (Prague, CZH), F. Cavaliere (Roma, Italy)

8h30-8h50: Cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal carcinomatosis. Results of the French multicentric database.

                 D. Elias (Villejuif, France)

8h50-9h10: French ongoing trials in the treatment of peritoneal carcinomatosis from colorectal cancer

                 F. Quenet (Montpellier, France)

9h10-9h30: USA ongoing trials in the treatment of peritoneal carcinomatosis from colorectal cancer

                J. Esquivel (Washington, USA)

9h30-9h50: Long term of randomized study in colorectal carcinomatosis

                 V. Verwaal (Amsterdam, Netherlands)

9h50-10h00: Discussion.

10h00-10h30: Coffee Break and Sponsor / Poster Visiting

10h30-12h40: Rare Peritoneal Surface Malignancies and                        Place of Pathologist

                       Chairmen: B. Moran (Basingstoke, UK), PJ Valette (Lyon, France),                                  JC Sabourin (Rouen, France)

10h30-10h50: Cytoreductive surgery and perioperative intraperitoneal chemotherapy for rare peritoneal disease. Results of the French multicentric database.

                    O. Glehen (Lyon, France)

10h50-11h10: The renewal of pseudomyxoma peritonei pathology

                    S. Bruin (Netherlands)

11h10-11h30: New prognostics factors for peritoneal mesotheliome

                    M. Deraco (Milan, Italy)

11h30-11h50: French National Organization for the treatment of rare peritoneal disease:RENAPE. From a national to an international cooperation.

                    FN Gilly (Lyon, France)

11h50-12h10: Multi-institutional prospective data registery for peritoneal mesotheliome

                    TD Yan (Sydney, Australia)

12h10-12h40: Discussion.

12h40-14h30: Lunch and Sponsor / Poster Visiting

                        Restaurant GAMBONI

14h30-15h45: Gastric Cancer

               Chairmen : P. Shen (Winston Salem, USA), TD Yan (Sydney, Australia)

14h30-14h50: Place of hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis from gastric cancer. Results of French multicentric database.

                    C. Arvieux (Grenoble, France)

14h50-15h10: Neoadjuvant intrapertoneal chemotherapy in advanced gastric cancer.

                    Y. Yonemura (Japan)

15h10-15h30: Prevention of peritoneal carcinomatosis in gastric cancer.

                    A. Garofalo (Roma, Italy)

15h30-15h45: Discussion.

15h45-17h30: Hyperthermic Intraperitoneal Chemotherapy: Unusual Indications.

               Chairmen: D. Elias (Villejuif, France), M. Gutman (Tel Aviv, Israel)

15h45-16h05: Second look for patients at risk of peritoneal carcinomatosis and place of prophylactic hyperthermic intraperitoneal chemotherapy.

                    H. Mahteme (Uppsala, Sweden)

16h05-16h25: Place of hyperthermic intraperitoneal chemotherapy as palliative treatment (ascitis)

                    S. Miska (Paris, France)

16h25-16h35: Discussion.


17h00-17h10: HIPEC feasible by everybody: the hotwire revolution.Video-session.

                   Patrick Rat (France)

17h10-17h20: Early experience with cytoreductive surgery and continuous hyperthermic peritoneal perfusion (CHPP) in children.  

                    Andrea Hayes-Jordan (Houston, USA)

17h20-17h30: Thoracic cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy for pseudomyxoma peritonei.

                    Terence C. Chua (Sydney, Australia)

17h30-18h45: FREE PAPER SESSION n1

          Chairmen: S. Gonzales Moreno (Madrid, Spain), F. Quenet (MontpellierFrance)

20h30:        DINER DE GALA

                                            Casino Lyon Vert La Tour de Salvagny       


Wednesday, November 19th

8h30-10h30: Pharmacokinetics and Biological Session

                Chairmen: F. Mohamed (Basingstoke, UK), B. Tranchand (Lyon, France)

8h30-8h45: Pharmacokinetics of intraperitoneal cisplatinium

                 E. Cotte (Lyon, France)

8h45-9h00: Effect of intraperitoneal pressure and adrenalin in pharmacokinetics of intraperitoneal drugs

                 B. Chauffert (Dijon, France)

9h00-9h20: Key points on pharmacokinetics of intraperitoneal chemotherapy

                 E. de Bruijn (Leuven, Belgium)

9h20-9h40: New targeted therapy: Application for loco-regional therapy

                 JF Pingpank (Bethesda, USA)

9h40-10h00: Chemotherapy, environmental and juridic aspects.

                  AC Sayag-Beaujard (Lyon, Frace)

10h00-10h30: Discussion.

10h30-11h00: Coffee Break and Sponsor / Poster Visiting

11h00-12h00:   FREE PAPER SESSION n2

12h00-13h30: LUNCH

13h30-15h30:    Ovarian Cancer

                    Chairmen: G. Freyer (Lyon, France), AA Tentes (Didimotichon, Greece)

13h30-13h50: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian cancer. French experience.

                     JM Bereder (Nice, France)

13h50-14h10: Place of hyperthermic intraperitoneal chemotherapy in ovarian cancer. The surgeon's point of view.

                     W. Helm (Louisville, USA)

14h10-14h30: Place of hyperthermic intraperitoneal chemotherapy in ovarian cancer. The medical oncologist's point of view.

                     I. Ray Coquard (Lyon, France)

14h30-14h40: Perspectives in clinical research for the treatment of peritoneal carcinomatosis in ovarian cancer

                     M. Deraco (Milan, Italy)

14h40-15h30: Discussion.

15h30:         CEREMONY

Lyon University Honoris Causa Distinctions to Paul Sugarbaker.
By decision of the French Education and Research Ministry.

home of the peritoneal workshop | back | mail | credits